Data as of Dec 10
| -5.34 / -6.02%|
The 3 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 64.00, with a high estimate of 71.00 and a low estimate of 61.00. The median estimate represents a -23.21% decrease from the last price of 83.34.
The current consensus among 4 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.